Doctor profile · Federal record
Dr. Kartik Konduri, MD
Medical Oncology Physician (CMS: Medical Oncology) · Hematology & Oncology Physician · Dallas, TX
- NPI 1417995499
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3410 Worth St
Dallas, TX 752462003
(214) 370-1000
fax (214) 370-1202 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- November 30, 2023
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #L3363
- Medicaid (5)
- TX #078671702 · TX #078671704 · TX #078671703 · TX #078671706 · TX #078671705
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1417995499. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
96,810
Distinct HCPCS
10
Medicare allowed
$1,921,995
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 23,300 | 64 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 19,350 | 78 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 11,864 | 43 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 10,595 | 103 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 8,670 | 17 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 4,680 | 12 | $47 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,985 | 138 | $0 | |
J9171 |
Injection, docetaxel, 1 mg | 2,226 | 13 | $1 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,801 | 101 | $1 | |
J0897 |
Injection, denosumab, 1 mg | 1,560 | 11 | $23 |
In context: peer comparison
Among 27 peers in Dallas Medical Oncology Physician, average services per provider: 1,011. This provider delivers 96× the peer median.Open Payments
Industry payments received
All-time total
$21,537
Transactions
17
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | 5 | $6,424.12 | |
| Janssen Biotech, INC. | 2 | $5,336.75 | |
| Amgen INC. | 2 | $2,864.54 | |
| Abbvie INC. | 2 | $1,813.90 | |
| Pfizer INC. | 1 | $1,440.00 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $1,420.00 | |
| Daiichi Sankyo INC. | 1 | $1,300.00 | |
| Janssen Scientific Affairs, LLC | 1 | $817.50 | |
| Regeneron Pharmaceuticals, INC. | 1 | $103.65 | |
| Regeneron Healthcare Solutions, INC. | 1 | $17.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
285
Patients
85
Total drug cost
$985,179
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 92 | 46 | $1,496 |
| Tagrisso (Osimertinib Mesylate) | Brand | 48 | 0 | $827,791 |
| Eliquis (Apixaban) | Brand | 36 | 0 | $22,265 |
| Ondansetron Hcl | Generic | 36 | 25 | $303 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 21 | 14 | $148 |
| Prednisone | Generic | 15 | 0 | $136 |
| Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) | Brand | 13 | 0 | $135 |
| Pantoprazole Sodium | Generic | 12 | 0 | $192 |
| Tabrecta (Capmatinib Hydrochloride) | Brand | 12 | 0 | $132,712 |
Hospital affiliations
Frequently asked questions
What is Dr. Kartik Konduri's medical specialty?
Dr. Kartik Konduri practices Medical Oncology Physician in Dallas, TX.
Where does Dr. Kartik Konduri practice?
Dr. Kartik Konduri practices at 3410 Worth St, Dallas, TX 752462003. Office phone: 2143701000.
What is Dr. Kartik Konduri's NPI?
Dr. Kartik Konduri's National Provider Identifier (NPI) is 1417995499, issued by NPPES.
Does Dr. Kartik Konduri accept Medicare assignment?
Yes. Dr. Kartik Konduri accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kartik Konduri commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, paclitaxel, 1 mg (HCPCS J9267). Source: CMS Medicare Physician & Other Practitioners file.